Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor

2017 
Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    33
    References
    80
    Citations
    NaN
    KQI
    []